Chapter 22. Anti-Inflammatory Immune Therapy in Heart Disease

  1. Ronald Ross Watson1,2 and
  2. Douglas F. Larson3
  1. David Chen,
  2. Christian Assad‒Kottner,
  3. Francisco J. Cordova,
  4. Carlos Orrego and
  5. Guillermo Torre‒Amione

Published Online: 15 APR 2008

DOI: 10.1002/9780470692325.ch22

Immune Dysfunction and Immunotherapy in Heart Disease

Immune Dysfunction and Immunotherapy in Heart Disease

How to Cite

Chen, D., Assad‒Kottner, C., Cordova, F. J., Orrego, C. and Torre‒Amione, G. (2008) Anti-Inflammatory Immune Therapy in Heart Disease, in Immune Dysfunction and Immunotherapy in Heart Disease (eds R. R. Watson and D. F. Larson), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470692325.ch22

Editor Information

  1. 1

    Department of Nutritional Sciences, The University of Arizona; and Sarver Heart Center, College of Medicine, The University of Arizona

  2. 2

    Division of Health Promotion Sciences, Mel and Enid Zuckerman Arizona College of Public Health, The University of Arizona Tucson, AZ USA

  3. 3

    Sarver Heart Center College of Medicine The University of Arizona Tucson, AZ USA

Publication History

  1. Published Online: 15 APR 2008
  2. Published Print: 30 AUG 2007

ISBN Information

Print ISBN: 9781405155687

Online ISBN: 9780470692325

SEARCH

Keywords:

  • immune therapy;
  • heart disease;
  • cytokines;
  • clinical benefits;
  • myocarditis

Summary

This chapter contains section titled:

  • Introduction

  • Anticytokine therapy-why did it fail?

  • TNF-á and hypertrophy

  • Immune system redundancy

  • A new era of broad-spectrum anti-inflammatory treatments in HF

  • Immunoglobulin

  • Immune adsorption

  • Plasmapheresis

  • Statin therapy

  • Immune modulation therapy

  • Conclusion

  • References